407 related articles for article (PubMed ID: 18607173)
1. Impact of statins on modulation by insulin of expression of plasminogen activator inhibitor type-1.
Sato Y; Dong J; Imagawa S; Ishimori N; Furumoto T; Tsutsui H; Sobel BE; Fujii S
Coron Artery Dis; 2008 Aug; 19(5):355-61. PubMed ID: 18607173
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of plasminogen activator inhibitor type-1 (PAI-1) in HEPG2 cells induced by insulin mediated by the 3'-untranslated region of the PAI-1 gene and its pharmacologic implications.
Miyagawa R; Asakura T; Nakamura T; Okada H; Iwaki S; Sobel BE; Fujii S
Coron Artery Dis; 2010 May; 21(3):144-50. PubMed ID: 20299979
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor regulates E box-dependent plasminogen activator inhibitor type 1 gene expression in HepG2 liver cells.
Imagawa S; Fujii S; Dong J; Furumoto T; Kaneko T; Zaman T; Satoh Y; Tsutsui H; Sobel BE
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2407-13. PubMed ID: 16902162
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 and mevastatin regulate plasminogen activator inhibitor-1 through CCAAT/enhancer-binding protein-delta.
Dong J; Fujii S; Li H; Nakabayashi H; Sakai M; Nishi S; Goto D; Furumoto T; Imagawa S; Zaman TA; Kitabatake A
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1078-84. PubMed ID: 15718495
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha-induced production of plasminogen activator inhibitor 1 and its regulation by pioglitazone and cerivastatin in a nonmalignant human hepatocyte cell line.
Takeshita Y; Takamura T; Hamaguchi E; Shimizu A; Ota T; Sakurai M; Kaneko S
Metabolism; 2006 Nov; 55(11):1464-72. PubMed ID: 17046548
[TBL] [Abstract][Full Text] [Related]
6. Effects of simvastatin on cigarette smoke extract induced tissue-type plasminogen activator and plasminogen activator inhibitor-1 expression in human umbilical vein endothelial cells.
Hu XY; Ma YH; Wang C; Yang YH
Chin Med J (Engl); 2009 Oct; 122(19):2380-5. PubMed ID: 20079143
[TBL] [Abstract][Full Text] [Related]
7. The MAPK pathway and HIF-1 are involved in the induction of the human PAI-1 gene expression by insulin in the human hepatoma cell line HepG2.
Dimova EY; Kietzmann T
Ann N Y Acad Sci; 2006 Dec; 1090():355-67. PubMed ID: 17384280
[TBL] [Abstract][Full Text] [Related]
8. Modulators of induction of plasminogen activator inhibitor type-1 in HepG2 cells by transforming growth factor-β.
Nakayama N; Nakamura T; Okada H; Iwaki S; Sobel BE; Fujii S
Coron Artery Dis; 2011 Nov; 22(7):468-78. PubMed ID: 21968503
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin inhibits tissue factor and plasminogen activator inhibitor-1 secretion by peripheral blood mononuclear cells in patients with primary nephrotic syndrome.
Wei JL; Cui HM; Ma CY
Eur J Med Res; 2007 May; 12(5):216-21. PubMed ID: 17513194
[TBL] [Abstract][Full Text] [Related]
10. Effect of fatty acid chain length and thioesterification on the augmentation of expression of plasminogen activator inhibitor-1.
Chen Y; Sobel BE; Schneider DJ
Nutr Metab Cardiovasc Dis; 2002 Dec; 12(6):325-30. PubMed ID: 12669679
[TBL] [Abstract][Full Text] [Related]
11. Lovastatin inhibits oxidized low-density lipoprotein-induced plasminogen activator inhibitor and transforming growth factor-beta1 expression via a decrease in Ras/extracellular signal-regulated kinase activity in mesangial cells.
Song CY; Kim BC; Lee HS
Transl Res; 2008 Jan; 151(1):27-35. PubMed ID: 18061125
[TBL] [Abstract][Full Text] [Related]
12. Rosiglitazone prevents advanced glycation end products-induced renal toxicity likely through suppression of plasminogen activator inhibitor-1.
Yu X; Li C; Li X; Cai L
Toxicol Sci; 2007 Apr; 96(2):346-56. PubMed ID: 17264099
[TBL] [Abstract][Full Text] [Related]
13. [Effect of aldosterone on the expression of plasminogen activator inhibitor-1 in renal mesangial cells: experiment with rat renal mesangial cells].
Yuan J; Jia RH; Bao Y
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2439-42. PubMed ID: 18036328
[TBL] [Abstract][Full Text] [Related]
14. Transmembrane signaling pathway mediates oxidized low-density lipoprotein-induced expression of plasminogen activator inhibitor-1 in vascular endothelial cells.
Sangle GV; Zhao R; Shen GX
Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1243-54. PubMed ID: 18796547
[TBL] [Abstract][Full Text] [Related]
15. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Barret's adenocarcinoma cell growth by simvastatin: involvement of COX-2 and apoptosis-related proteins.
Konturek PC; Burnat G; Hahn EG
J Physiol Pharmacol; 2007 Aug; 58 Suppl 3():141-8. PubMed ID: 17901590
[TBL] [Abstract][Full Text] [Related]
17. TNF-α modulates statin effects on secretion and expression of MCP-1, PAI-1 and adiponectin in 3T3-L1 differentiated adipocytes.
Lobo SM; Quinto BM; Oyama L; Nakamichi R; Ribeiro AB; Zanella MT; Dalboni MA; Batista MC
Cytokine; 2012 Oct; 60(1):150-6. PubMed ID: 22658637
[TBL] [Abstract][Full Text] [Related]
18. Effect of Tisseel on expression of tissue plasminogen activator and plasminogen activator inhibitor-1.
Diamond MP; Kruger M; Saed GM
Fertil Steril; 2004 Jun; 81(6):1657-64. PubMed ID: 15193491
[TBL] [Abstract][Full Text] [Related]
19. Type 1 plasminogen activator inhibitor is not an acute phase reactant in rats. Lack of IL-6- and hepatocyte-dependent synthesis.
Podor TJ; Hirsh J; Gelehrter TD; Zeheb R; Torry D; Guigoz Y; Sierra F; Gauldie J
J Immunol; 1993 Jan; 150(1):225-35. PubMed ID: 7678029
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1beta enhances the angiotensin-induced expression of plasminogen activator inhibitor-1 through angiotensin receptor upregulation in human astrocytes.
Yoshida H; Imaizumi T; Tanji K; Sakaki H; Metoki N; Sato Y; Wakabayashi K; Kimura H; Satoh K
Brain Res; 2006 Feb; 1073-1074():38-47. PubMed ID: 16427616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
